Past The Peak? Covid Drugs Frenzy Cools As Pandemic Eases
The drugs Xiannuoxin and Mindewei have been conditionally approved for marketing in China.
Simcere Xiannuoxin Merck Molnupiravir Junshi Biosciences Simcere Covid Ascletis Pharma Municipal Medical Insurance Bureau
Source: seekingalpha.com